#9813 on the rich list of 14,644 insiders
Carole Ho
Chief Medical Officer at Denali Therapeutics; Director at Royalty Pharma. Based in New York, New York.
$8.6M
in disclosed stock, −$97K (−1.12%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 9813th of 14,644
- Companies held
- 2
- Largest holding
- DNLI, 89.7% of total
- Latest SEC filing
- Jun 5, 2026
What the $8.6M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Denali Therapeutics DNLI Common Stock | Directly | 216,585 | $18.20 | $3.9M | 45.7% | Form 4, Aug 13, 2025 |
| Denali Therapeutics DNLI Common Stock | Through Rohatgi-Ho Family 2009 Revocable Trust | 183,219 | $18.20 | $3.3M | 38.7% | Form 4, Aug 12, 2025 |
| Royalty Pharma RPRX Class A Ordinary Shares | Through Rohatgi-Ho Family 2009 Revocable Trust | 8,558 | $67.72 | $580K | 6.7% | Form 4, Jun 5, 2026 |
| Denali Therapeutics DNLI Common Stock | Through Rohatgi-Ho Irrevocable GST Trust | 25,000 | $18.20 | $455K | 5.3% | Form 4, Aug 12, 2025 |
| Royalty Pharma RPRX Class A Ordinary Shares | Directly | 4,545 | $67.72 | $308K | 3.6% | Form 4, Jun 5, 2026 |
Share counts are the amounts Carole Ho reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 9810 | Michael Filip Horodniceanu Director, Tutor Perini. Sylmar, CA | $8.6M |
| 9811 | Enderson Guimaraes Director, AutoZone. Irving, TX | $8.6M |
| 9812 | Paul J. Ferdenzi Insider, Curtiss-Wright. Davidson, NC | $8.6M |
| 9813 | Carole Ho Chief Medical Officer, Denali Therapeutics. New York, NY | $8.6M |
| 9814 | Cristina Gallo-Aquino EVP and CFO, Ryder System. Coral Gables, FL | $8.6M |
| 9815 | Marianne Catherine Brown Director, Northrop Grumman. Falls Church, VA | $8.6M |
| 9816 | Amir Panush Chief Executive Officer, CEVA. Rockville, MD | $8.6M |
Other Denali Therapeutics insiders
All DNLI insiders- Ryan J. Watts$44.0MPresident and CEO. #2789 overall
- Marc Tessier-Lavigne$35.8MDirector. #3115 overall
- Steve Krognes$14.9MDirector. #6089 overall
- Alexander O. Schuth$14.6MCOFO and Secretary. #6576 overall
- Jay T. Flatley$6.5MDirector. #9870 overall
- Vicki L. Sato$2.0MDirector. #7844 overall
Questions
How much stock does Carole Ho own?
Carole Ho holds $8,618,768 in listed stock based on SEC filings and current prices, mostly Denali Therapeutics (DNLI). That ranks 9813th on the Stock Rich List.
Is this Carole Ho's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.